• Duality Biologics Completed $90 Million Series B Financing prnasia
    May 20, 2021
    Duality Biologics, an innovative biotech company, announced the completion of $90 million series B financing today. This round of financing was led by Lilly Asia Ventures (LAV) and jointly invested by YUNION Healthcare Fund, Huagai Capital ...
PharmaSources Customer Service